Impact of a code stroke protocol on the door-to-needle time for IV thrombolysis: a feasibility study
暂无分享,去创建一个
E. Achten | M. Acou | D. Hemelsoet | V. De Herdt | S. Hachimi-Idrissi | Joke Vanhoucke | Elke Vereecke
[1] Atte Meretoja,et al. Reducing in-hospital delay to 20 minutes in stroke thrombolysis , 2012, Neurology.
[2] R. M. Van den Berg-Vos,et al. Achieving a door-to-needle time of 25 minutes in thrombolysis for acute ischemic stroke: a quality improvement project. , 2014, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.
[3] D. Pandey,et al. Epidemiology of ischemic and hemorrhagic stroke: incidence, prevalence, mortality, and risk factors. , 2008, Neurologic clinics.
[4] L. Goldstein,et al. BE-FAST (Balance, Eyes, Face, Arm, Speech, Time): Reducing the Proportion of Strokes Missed Using the FAST Mnemonic , 2017, Stroke.
[5] Eric E. Smith,et al. Improving Door-to-Needle Times in Acute Ischemic Stroke: The Design and Rationale for the American Heart Association/American Stroke Association's Target Stroke Initiative , 2011, Stroke.
[6] Gregory W Albers,et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials , 2010, The Lancet.
[7] Adrian F Hernandez,et al. Timeliness of Tissue-Type Plasminogen Activator Therapy in Acute Ischemic Stroke: Patient Characteristics, Hospital Factors, and Outcomes Associated With Door-to-Needle Times Within 60 Minutes , 2011, Circulation.
[8] L. Beenen,et al. Thrombolysis in Stroke within 30 Minutes: Results of the Acute Brain Care Intervention Study , 2016, PloS one.
[9] J. Willey,et al. Symptomatic intracerebral hemorrhage in acute ischemic stroke after thrombolysis with intravenous recombinant tissue plasminogen activator: a review of natural history and treatment. , 2014, JAMA neurology.
[10] Atte Meretoja,et al. Helsinki model cut stroke thrombolysis delays to 25 minutes in Melbourne in only 4 months , 2013, Neurology.
[11] Eric E. Smith,et al. Use of Strategies to Improve Door-to-Needle Times With Tissue-Type Plasminogen Activator in Acute Ischemic Stroke in Clinical Practice: Findings from Target Stroke , 2017, Circulation. Cardiovascular quality and outcomes.